OHSU

2010 Startup Companies

Aronora

Aronora, LLC is a biotech company established for the commercialization of proprietary anticoagulant products that do not cause bleeding and can be safely used in hard to treat blood clot diseases, such as ischemic stroke, heart attack, or those associated with severe infections.

 

Gamma Therapeutics

Gamma Therapeutics is a biopharmaceutical company founded by Dr. David Farrell, PhD,, Professor of Pathology at OHSU. The company is focused on the development of diagnostics and drugs for the treatment of heart attacks.

Gamma Therapeutics was also a finalist in the seed stage at the 2010 Angel Oregon investment competition and received nearly 1.5 million in Small Business Innovation Research (SBIR) funding from the National Heart, Lung, and Blood Institute (NHLBI).

Visit Gamma Therapeutics website.

 

Odyssey Science Innovations

Odyssey Science Innovations is a sports medicine company focused on the health and well-being of male and female adolescent athletes through its series of educational programs, ATLAS and ATHENA.

ATLAS (Athletes Training & Learning to Avoid Steriods) targets male adolescent athletes' use of anabolic steroids, alcohol, and other drugs and use of sport supplements, while improving healthy nutrition and exercise practices. ATHENA (Athletes Targeting Healthy Exercise & Nutrition & Nutrition Alternatives) is a school-based team-centered prevention program for female athletes on middle and high school sports, dance and cheerleading teams.

A Small Business Technology Transfer (STTR) awardee, Odyssey received over $150,000 in funding from the National Institute on Drug Abuse (NIDA).

 

Printable PDF of the 2010 Startup Document